Nasdaq

Sean Salmon Named EVP & President Cardiovascular Portfolio; Continues as EVP & President Diabetes Operating Unit

DUBLIN, Dec. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice President ...
Morningstar

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean ...
FierceBiotech

Coyle exits Medtronic to run iRhythm as diabetes lead Salmon takes over cardiovascular unit

Medtronic is shifting its C-suite after its cardiovascular portfolio lead and 11-year veteran Mike Coyle jumps ship at year-end to run wearable electrocardiogram maker iRhythm Technologies. He will be ...
Morningstar

Medtronic Names Kiil Head of Cardiovascular Business as Salmon Departs

The top executive of Medtronic's cardiovascular portfolio, Sean Salmon, is leaving the medical-technology company. Medtronic on Wednesday said Skip Kiil, previously senior vice president and president ...